Lymphatic System
The lymphatic system is a one-way drainage network beginning with blind-ended lymphatic capillaries in nearly every vascularised tissue, converging through collecting vessels and 400–700 lymph nodes, and emptying into the venous circulation at the thoracic duct (left subclavian vein) and right lymphatic duct. Three core functions: (1) fluid homeostasis — returns ~3 L/day of Starling filtrate not reabsorbed by venous capillaries; (2) immune surveillance — highways for DCs carrying antigens from tissues to lymph nodes where adaptive responses initiate; (3) lipid transport — chylomicrons enter intestinal lacteals bypassing the portal route. The spleen (largest secondary lymphoid organ) and thymus (T-cell education) complete the system.
Overview
The lymphatic system operates in parallel with and complementary to the cardiovascular system. Unlike the closed cardiovascular circuit, the lymphatics form a one-way drainage network. The critical driving pressure is tissue interstitial pressure: Starling forces at capillary beds net ~3 L/day of protein-rich plasma filtrate into the interstitium that venous capillary reabsorption cannot fully reclaim — the lymphatics collect and return this fluid, preventing progressive oedema.
The system's immune function is equally fundamental: lymphatic capillaries are the highway by which antigen-bearing dendritic cells (DCs) travel from peripheral tissues to regional lymph nodes — the anatomical encounter point where naïve T and B cells are activated to initiate adaptive immune responses. Dietary fat absorption adds a third dimension: chylomicrons (75–1200 nm) are too large for blood capillary junctions and exclusively enter intestinal lacteals → thoracic duct → systemic circulation, bypassing first-pass hepatic metabolism.
Key Components
| Component | Structure | Function |
|---|---|---|
| Lymphatic capillaries | Blind-ended; button junctions (overlapping VE-cadherin flaps); no basement membrane; anchoring filaments; LYVE-1+, podoplanin+, PROX1+, VEGFR3+ | One-way uptake of interstitial fluid, macromolecules, lipid particles, and immune cells; ~0 mmHg intraluminal pressure |
| Collecting lymphatics | Zipper junctions (less permeable); lymphatic smooth muscle (intrinsic ~10 contractions/min); bicuspid valves every 1–2 cm (lymphangions); sympathetic adrenergic innervation | Active propulsion of lymph toward lymph nodes; valves prevent backflow; augmented by skeletal muscle pump, respiration, and arterial pulsatility |
| Lymph nodes (400–700) | Subcapsular sinus (CD169+ macrophages, DCs); cortex (B cell follicles, germinal centres, FDCs); paracortex (T cell zone, HEV, DCs); medullary cords (plasma cells) | Antigen filtration and immune activation hub; HEV enable naïve lymphocyte recirculation; GC → affinity maturation → IgG plasma cells + memory B cells |
| Thoracic duct | 38–45 cm; ~5 mm diameter; drains left upper body + all of lower body → left subclavian vein; right lymphatic duct drains right upper body | Returns 2–4 L/day lymph + dietary chylomicrons to venous circulation |
| Spleen (~150 g) | Red pulp: splenic cords + venous sinuses (2–3 µm gaps); white pulp: PALS + B cell follicles + marginal zone (MZ B cells) | Red pulp: RBC quality control (senescent RBCs trapped), iron recycling, platelet reservoir; White pulp: adaptive immunity to blood-borne antigens; MZ: T-independent IgM to polysaccharide antigens |
| Thymus | Bilobed, anterior mediastinum; cortex (DP thymocytes + cTECs, positive selection); medulla (SP thymocytes + mTECs/AIRE, negative selection); Hassall's corpuscles | T-cell education: V(D)J rearrangement, positive selection (self-MHC recognition), negative selection (AIRE-driven self-antigen deletion → autoimmune prevention); involutes with age |
| MALT | Tonsils (Waldeyer's ring); Peyer's patches (ileum, M-cell antigen sampling); BALT (induced); mesenteric lymph nodes | Mucosal immune surveillance; IgA production → sIgA → luminal protection without inflammation |
Key Functions
Fluid homeostasis (Starling forces): At the arterial end of capillaries, hydrostatic pressure (~35 mmHg) exceeds oncotic pressure (~28 mmHg) → net filtration (~20 mL/min systemic). At the venous end, net reabsorption is slightly less → ~3 L/day accumulates in interstitium → must be drained by lymphatics to prevent progressive oedema. Failure → lymphoedema.
Immune surveillance: The lymph node is the critical encounter point between antigen-bearing DCs (arriving via afferent lymph, guided by CCL19/21 gradient through CCR7 expression) and recirculating naïve lymphocytes (entering via HEV using L-selectin/PNAd tethering → LFA-1/ICAM-1 arrest). DC-T cell cognate interaction (TCR-pMHC + CD28-B7 + cytokines) → T cell activation → clonal expansion → Tfh-B cell interaction → germinal centre → affinity maturation → class switch → plasma cells and memory B cells exit via efferent lymphatics → blood → effector tissues.
Dietary lipid transport: Enterocytes package dietary TG + cholesterol + apoB-48 into chylomicrons (75–1,200 nm) — too large for blood capillary junctions. Chylomicrons enter intestinal lacteals via button junctions → mesenteric lymphatics → cisterna chyli → thoracic duct → left subclavian vein. This explains why fat-soluble vitamins (A, D, E, K) and lipophilic drugs initially bypass hepatic first-pass metabolism.
Lymph Node Immune Architecture
Tissue injury / pathogen
│ DC maturation → CCR7 ↑
▼
Afferent lymphatic → subcapsular sinus
(SCS macrophages trap large antigens + cell debris;
relay to follicular DCs and B cells)
│
▼
Paracortex (T-cell zone)
DC presents antigen on MHC-I (CD8 CTL) / MHC-II (CD4 Th)
+ CD28-B7 co-stimulation + cytokine signals
│ T cell activation + clonal expansion
│ Tfh cells differentiate → migrate to follicle
▼
Secondary follicle → GERMINAL CENTRE
Centroblasts (rapid division + somatic hypermutation)
→ centrocytes compete for FDC antigen
→ affinity selection → class switch recombination
│
├─► Long-lived plasma cells (bone marrow)
│ → high-affinity IgG/IgA/IgE
└─► Memory B cells (circulate indefinitely)
│
Medullary cords: plasma cell IgG/IgA secretion
Efferent lymphatic: antibodies + effector cells → blood
Spleen — Haematological and Immune Functions
Red pulp — quality control
~350 L of blood filtered daily. Senescent or deformed RBCs (↓deformability → cannot squeeze through 1–3 µm slit pores of venous sinuses) are trapped and phagocytosed by red pulp macrophages (CD163+). Iron recycled: Hb → haem oxygenase → biliverdin → bilirubin + iron → ferroportin → transferrin → bone marrow. Platelet reservoir (~30% sequestered at rest).
White pulp — adaptive immunity
PALS (periarteriolar lymphatic sheath): T cell zone surrounding central arteriole; T cell activation by blood-borne antigens. Follicles: B cell zone; secondary follicles develop GCs. Marginal zone (MZ) B cells: CD21hi, IgMhi, IgDlo; mount rapid T-independent IgM responses to polysaccharide antigens (encapsulated bacteria). Splenectomy → loss of MZ → ↑OPSI risk.
Pathology
Lymphoma — Hodgkin and Non-Hodgkin
Hodgkin Lymphoma (HL): Reed-Sternberg cells (binucleate CD30+, CD15+, PAX5 dim, CD45−; GC B-cell origin; lost BCR expression; NF-κB/JAK-STAT rescue; EBV ~40%). Nodular sclerosis most common (young adults, mediastinal). Treatment: ABVD → >85% cure early-stage; brentuximab vedotin (anti-CD30 ADC) for relapsed/refractory. NHL (>60 entities): DLBCL (30%, aggressive, R-CHOP; BCL6/MYC/BCL2 double/triple hit → poor prognosis), follicular lymphoma (t(14;18) BCL2 overexpression → indolent), Burkitt (t(8;14) MYC, EBV/HIV-associated, highly aggressive), CLL/SLL (CD5+, CD23+; ibrutinib/venetoclax), mantle cell (t(11;14) cyclin D1).
Lymphoedema
Primary: monogenic lymphatic development disorders — Milroy disease (VEGFR3/FLT4 loss → absent/hypoplastic lymphatics, bilateral leg oedema from birth), Meige disease / lymphoedema praecox (FOXC2 mutations, pubertal onset), Hennekam syndrome (CCBE1/ADAMTS3 → generalised lymphangiectasia). Secondary (far more common): filariasis (most common globally — W. bancrofti/B. malayi), breast cancer surgery + RT (20–30% arm lymphoedema), recurrent cellulitis. Treatment: complex decongestive therapy (CDT), pneumatic compression, vascularised lymph node transfer, lymphovenous anastomosis.
Overwhelming Post-Splenectomy Infection (OPSI)
Splenectomy removes marginal zone B cells (T-independent IgM responses to polysaccharide antigens) and reduces opsonisation → fulminant sepsis by S. pneumoniae (~50%), H. influenzae b, N. meningitidis. Lifetime risk ~1–5%; mortality ~50%. Prevention: pre-splenectomy vaccination (PCV13 + PPSV23, Hib, MenACWY, MenB) + lifelong penicillin prophylaxis (especially children/first 2 years) + antibiotic standby + medical alert.
Filariasis (Elephantiasis)
W. bancrofti and B. malayi/timori filarial nematodes (Culex/Anopheles mosquitoes) → adults in lymphatic vessels → host inflammatory response → lymphangitis + progressive fibrosis → chronic lymphoedema → elephantiasis. ~120 million infected globally; 40 million with clinical lymphoedema. Treatment: diethylcarbamazine (DEC) + albendazole + ivermectin (triple therapy, WHO 2022) kills microfilariae; doxycycline (kills endosymbiotic Wolbachia → adult worm sterilisation/death).
Kaposi Sarcoma and Chylothorax
Kaposi sarcoma: HHV-8 infects lymphatic endothelial cells → spindle cell tumour; forms: classic (elderly Mediterranean), endemic (African children), AIDS-related (now rare with ART), iatrogenic (transplant). Chylothorax: thoracic duct injury (trauma, oesophagectomy, lymphoma) → chyle in pleural space (milky, TG >110 mg/dL); treat: nil by mouth → MCT diet → octreotide → pleurodesis → TD ligation.
Cross-Atlas Connections
References
- Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology. 14th ed. Elsevier; 2021. elsevier.com
- Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 7th ed. W.W. Norton; 2022. NCBI Bookshelf
- Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev. 2001;50(1-2):3-20. doi:10.1016/S0169-409X(01)00150-8
- WHO. Lymphatic Filariasis. who.int
- Morton LM, et al. Lymphoma Incidence Patterns by WHO Subtype in the United States. Blood. 2006;107(1):265-276. doi:10.1182/blood-2005-06-2508